Multiple lipoma with hyperlipidemia in a multiple myeloma patient treated with bortezomib/dexamethazone

Leuk Res. 2010 Apr;34(4):e120-1. doi: 10.1016/j.leukres.2009.10.003. Epub 2009 Oct 28.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Boronic Acids / administration & dosage
  • Boronic Acids / adverse effects
  • Bortezomib
  • Dexamethasone / administration & dosage
  • Dexamethasone / adverse effects
  • Dose-Response Relationship, Drug
  • Humans
  • Hyperlipidemias / chemically induced
  • Hyperlipidemias / diagnosis*
  • Hyperlipidemias / etiology
  • Lipoma / chemically induced
  • Lipoma / complications
  • Lipoma / diagnosis*
  • Male
  • Middle Aged
  • Multiple Myeloma / complications
  • Multiple Myeloma / drug therapy*
  • Neoplasms, Multiple Primary / complications
  • Neoplasms, Multiple Primary / diagnosis
  • Pyrazines / administration & dosage
  • Pyrazines / adverse effects

Substances

  • Boronic Acids
  • Pyrazines
  • Bortezomib
  • Dexamethasone